AVO Insider Trading

Insider Ownership Percentage: 47.53%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Advanced Oncotherapy Insider Trading History Chart

This chart shows the insider buying and selling history at Advanced Oncotherapy by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Advanced Oncotherapy Share Price & Price History

Current Price: GBX 1.75
Price Change: Price Decrease of -0.175 (-9.09%)
As of 08/30/2023 05:23 PM ET

This chart shows the closing price history over time for AVO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Advanced Oncotherapy Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2022Enrico Cipro VanniInsiderBuy80,000GBX 13£10,400
12/23/2022Michael J SinclairInsiderBuy80,000GBX 12£9,600
3/2/2022Enrico Cipro VanniInsiderBuy100,000GBX 26£26,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Advanced Oncotherapy (LON:AVO)

17.83% of Advanced Oncotherapy stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Advanced Oncotherapy logo
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Read More on Advanced Oncotherapy

Today's Range

Now: GBX 1.75
Low: 1.75
High: 1.75

50 Day Range

MA: GBX 1.75
Low: 1.75
High: 1.75

52 Week Range

Now: GBX 1.75
Low: 1.75
High: 25.75


200,000 shs

Average Volume

1,265,205 shs

Market Capitalization

£9.49 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Advanced Oncotherapy?

Advanced Oncotherapy's top insider investors include:
  1. Enrico Cipro Vanni (Insider)
  2. Michael J Sinclair (Insider)
Learn More about top insider investors at Advanced Oncotherapy.